<https://serval.unil.ch/notice/serval:BIB_21E6A02CC97F#id>	<http://id.loc.gov/vocabulary/relators/aut>	<http://www.idref.fr/060740639/id> .
<https://serval.unil.ch/notice/serval:BIB_21E6A02CC97F#id>	<http://purl.org/dc/terms/bibliographicCitation>	"Guery B.. Clostridium difficile infection trials: what is the primary endpoint?2019." .
<https://serval.unil.ch/notice/serval:BIB_21E6A02CC97F#id>	<http://purl.org/ontology/bibo/doi>	"10.1016/S1473-3099(18)30626-1" .
<https://serval.unil.ch/notice/serval:BIB_21E6A02CC97F#id>	<http://purl.org/dc/elements/1.1/date>	"2019-03" .